Symphogen Competitors and Similar CompaniesClear all
Symphogen's competitors and similar companies include Epizyme and Achilles Therapeutics.
 Epizyme Epizyme is a clinical stage biopharmaceutical company focusing on treatments for blood cancer and tumors. |  Achilles Therapeutics Achilles Therapeutics is a developer of immunotherapies intended to offer therapies to treat cancer. | ||
Founding Date | Founding Date 2000 | Founding Date 2007 | Founding Date 2016 |
Type | Type Private | Type Public | Type Private |
Tags | |||
Locations | Locations Ballerup, DK HQ Somerville, US | Locations Cambridge, US HQ | Locations London, GB HQ Stevenage, GB |
Employees | Employees 196 | Employees 20364% increase | Employees 695% decrease |
Financial | |||
Net income | Net income N/A | Net income ($251.1m) (FY, 2021) | Net income ($69.7m) (FY, 2023) |
Funding | |||
Total funding raised | Total funding raised $ 387.2m | Total funding raised $ 51.5m | Total funding raised $ 138.1m |
For sources of this data, please see the company profile
View Company Profiles
Epizyme
HQ
Cambridge, US
Employees
203
Epizyme is a clinical stage biopharmaceutical company focusing on treatments for blood cancer and tumors.
View companyAchilles Therapeutics
HQ
London, GB
Employees
69↓ 5% decrease
Achilles Therapeutics is a developer of immunotherapies intended to offer therapies to treat cancer.
View company